A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...

An American College of Surgeons initiative reduced postoperative hospitalization among older adults with cancer, according to ...

Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...

New research shows that maintaining a healthy weight following a monoclonal gammopathy of undetermined significance diagnosis ...

According to research presented at the EAHAD 2024 Annual Congress, a new classification system enhances diagnosis and ...

Being obese at the time of MGUS diagnosis was associated with a 27% increase in the risk of progression to MM.

Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...

Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance and Highlights 2025 R&D ...

ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...

Blueprint Medicines Corporation ( NASDAQ: BPMC) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET ...

In the coming years, an unprecedented number of people will leave planet Earth—but it’s becoming increasingly clear that deep ...

CSL (ASX: CSL; USOTC: CSLLY) has unveiled four-year results from its pivotal HOPE-B study, demonstrating the long-term ...